share_log

RBC Capital Maintains Sector Perform on Adverum Biotechnologies, Lowers Price Target to $2

Benzinga ·  Mar 19 08:13

RBC Capital analyst Luca Issi maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Sector Perform and lowers the price target from $3 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment